Skip to main content
Watch Insiders
LXEO filings

Corporate insider profile

Richard Nolan Townsend Filing Activity

Latest reported as Chief Executive Officer of Lexeo Therapeutics, Inc. (LXEO).

Purchase filings
0
Reported companies
1
Net open-market value
-$149,731.22
Latest transaction
Aug 18, 2026

Affiliated corporations

Reported company relationships

LXEOLatest reported

Lexeo Therapeutics, Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 18, 2026Lexeo Therapeutics, Inc. (LXEO)Chief Executive OfficerSale3,345$4.95$16,562
Jul 1, 2026Lexeo Therapeutics, Inc. (LXEO)Chief Executive OfficerSale25,947$4.48$116,243
May 18, 2026Lexeo Therapeutics, Inc. (LXEO)Chief Executive OfficerSale3,342$5.06$16,927